Publication
Role of pharmacogenomics in predicting antidepressant response and individualizing therapy
| dc.contributor.author | Santos, Marlene | |
| dc.contributor.author | Carvalho, Serafim | |
| dc.contributor.author | Lima, Luís | |
| dc.contributor.author | Mota-Pereira, Jorge | |
| dc.contributor.author | Pimentel, Paulo | |
| dc.contributor.author | Maia, Dulce | |
| dc.contributor.author | Correia, Diana | |
| dc.contributor.author | Gomes, Sofia | |
| dc.contributor.author | Cruz, Agostinho | |
| dc.contributor.author | Medeiros, Rui | |
| dc.date.accessioned | 2022-02-17T16:35:59Z | |
| dc.date.available | 2022-02-17T16:35:59Z | |
| dc.date.issued | 2015-11 | |
| dc.description.abstract | Major Depressive Disorder (MDD) is a highly prevalent chronic psychiatric condition with significant morbidity. Despite several antidepressants drugs (AD) available, a wide fraction of patients fail to respond, present relapse or display treatment resistant depression (TRD). Pharmacogenomics could help identify patients at risk of relapse or TRD and possibly have a direct impact on personalizing therapy. Additionally, recent studies suggested that immune activation and cytokines may be involved in depression, and its normalization occurs after antidepressant treatment. The proinflammatory cytokines interleukin-18 (IL-18) and IL-6 are less reported in depression, but considered to be relevant since they have been found to be increased in patients with depression. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Oliveira, A. I., Pinho, C., Fonte, P., Sarmento, B., & Dias, A. C. (2015). Development of polymeric nanoparticles containing neuroprotective compounds of Hypericum perforatum. In R. A. Silva, P. Baylina, F. Q. Vieira, C. Barrias, M. Rubim, T. Coelho, C. Prudêncio, & Â. Jesus (Eds.), II Congresso Internacional da Saúde Gaia Porto: Livro de Resumos (pp. 15-16). Escola Superior de Tecnologia da Saúde do Instituto Politécnico do Porto. | pt_PT |
| dc.identifier.isbn | 978-989-20-6340-9 | |
| dc.identifier.uri | http://hdl.handle.net/10400.22/19991 | |
| dc.language.iso | eng | pt_PT |
| dc.publisher | ESTSP-IPP | pt_PT |
| dc.title | Role of pharmacogenomics in predicting antidepressant response and individualizing therapy | pt_PT |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Gaia Porto | pt_PT |
| oaire.citation.endPage | 17 | pt_PT |
| oaire.citation.startPage | 16 | pt_PT |
| oaire.citation.title | II Congresso Internacional da Saúde Gaia Porto: Livro de Resumos | pt_PT |
| person.familyName | Santos | |
| person.familyName | Oliveira Lima | |
| person.familyName | Cruz | |
| person.givenName | Marlene | |
| person.givenName | Luís Carlos | |
| person.givenName | Agostinho | |
| person.identifier | 1508370 | |
| person.identifier.ciencia-id | 8311-B967-31C4 | |
| person.identifier.ciencia-id | 9F16-0E29-D9FC | |
| person.identifier.orcid | 0000-0001-5020-5942 | |
| person.identifier.orcid | 0000-0001-8152-9237 | |
| person.identifier.orcid | 0000-0002-1157-8196 | |
| person.identifier.scopus-author-id | 57110502000 | |
| person.identifier.scopus-author-id | 23501978900 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | conferenceObject | pt_PT |
| relation.isAuthorOfPublication | 8ce9ee39-a4c6-46ae-99e2-49397b550f1b | |
| relation.isAuthorOfPublication | c6b00c1f-f4c9-4f4f-b291-17cf30b1e1f8 | |
| relation.isAuthorOfPublication | d7ec3c5d-b3e0-4e34-8e24-4d1588876120 | |
| relation.isAuthorOfPublication.latestForDiscovery | d7ec3c5d-b3e0-4e34-8e24-4d1588876120 |
